Log in or Sign up for Free to view tailored content for your specialty!
Melanoma/Skin Cancer News
Expert advises continued sunscreen use with ‘total photoprotection package’
MAUI, HAWAII — New developments in photoprotection should prompt dermatologists to remind patients that photoprotection involves more than just sunscreen, according to a presenter here at Maui Derm for Dermatologists 2020.
ASTRO issues guidelines on radiation therapy for basal, cutaneous squamous cell carcinoma
American Society for Radiation Oncology has issued guidelines on the use of radiation therapy in the management of basal and cutaneous squamous cell carcinomas.
Log in or Sign up for Free to view tailored content for your specialty!
FDA: Some sunscreen ingredients exceed safety threshold, but still OK to use
Six active ingredients in four different commercially-available sunscreen formulations applied by healthy study participants were systemically absorbed through the skin, resulting in exposure levels that exceeded the FDA threshold for safety testing, researchers reported in JAMA.
Cancer mortality rate drops 29% between 1991 and 2017
Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to data from Cancer Statistics 2020, American Cancer Society’s annual report on cancer rates and trends.
Infections caused 13% of cancers in 2018
In 2018, infections were the cause of 13% of all new cancer diagnoses, totaling 2.2 million new cases worldwide, although these totals do not include nonmelanoma skin cancers, according to findings published in The Lancet Global Health.
$1 million grants fund research into melanoma metastasis
American Cancer Society and Melanoma Research Alliance provided two $1 million grants that will fund research focused on metastasis of melanoma and other cancer types.
Vismodegib induces long-term response after discontinuation in locally advanced basal cell carcinoma
A substantial proportion of patients with locally advanced basal cell carcinoma demonstrated long-term responses to vismodegib after discontinuation of the drug, according to results of a retrospective study published in Journal of Clinical Oncology.
Is it feasible to change the immunotherapy dose schedule for a patient in complete response?
Click here to read the Cover Story, “Cancer drug doses: More is not always better.”
Cancer drug doses: More is not always better
Historically, the goal of cancer treatment has been to destroy as many cancer cells as possible through chemotherapy or radiation.
31-GEP test shows clinical utility in cutaneous melanoma
An independent review of currently available literature showed that the 31-gene expression profile test in cutaneous melanoma may be supported by more evidence than designations by three major dermatology organizations would indicate.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read